Skip to main content
Homepage Insights News & Events News

LOGEX, Ivbar and Prodacapo have joined forces

Work highlight
16-10-2018
Loyens & Loeff advised LOGEX on its decision to, together with Ivbar and Prodacapo join forces through the new LOGEX Group. This will create a European market leader in advanced software for analysing outcomes and costs in healthcare.
Other recent news
  • Nasdaq Investment Firm obtains AFM licence for European trajectory trading
    09-11-2026
    Nasdaq Investment Firm obtains AFM licence for European trajectory trading
    We advised Nasdaq Investment Firm B.V. on obtaining its investment firm licence from the Dutch Authority for the Financial Markets (AFM).
    Work highlight
  • Loyens & Loeff advises the shareholders of Blauwhoed on its sale to BPD Europe
    09-11-2026
    Loyens & Loeff advises the shareholders of Blauwhoed on its sale to BPD Europe
    We advised the shareholders of Blauwhoed on the proposed sale of the company to BPD Europe.
    Work highlight
  • Loyens & Loeff named European Practice of the Year and recognised in GRR 30
    06-11-2026
    Loyens & Loeff named European Practice of the Year and recognised in GRR 30
    Loyens & Loeff has won the European Practice of the Year award at the Global Restructuring Review (GRR) Awards, recognising the strength of our Restructuring & Insolvency practice and our work on complex matters across Europe.
    Corporate News
Logo Loyens & Loeff
Netherlands Belgium Luxembourg Switzerland
Legal & Privacy